Q3 2025 Asker Healthcare Group AB Earnings Call Transcript
Key Points
- Asker Healthcare Group AB (FRA:I88) reported a 25% increase in earnings for Q3, with 6% of this growth being organic.
- The company's EBITA margin has increased to 9.3%, moving closer to the midterm target of 10%.
- Strong performance was noted in the West and Central regions, with significant contributions from recent acquisitions.
- The company has a robust acquisition pipeline, having completed 12 acquisitions in 2025, which are contributing positively to the EBITA margin.
- Asker Healthcare Group AB maintains a high capital efficiency with a stable R/RK (EBITA over networking capital) at 66%.
- The North region experienced weaker performance due to the absence of project-based defense sales that were present in 2024.
- There is a small FX headwind affecting the financial results, although it has moderated since Q2.
- The company's leverage is at 2.2%, which is within the target range but indicates a reliance on debt for acquisitions.
- The Q3 period is typically the smallest quarter due to holiday effects, which can impact overall performance.
- There is uncertainty regarding the timing of future defense contracts, which could affect future earnings in the North region.
Hello. Welcome to Asker Q3 interim report. This is Johan Falk speaking, the CEO. I'm happy to present the third quarter result that was increasing with 25%, out of which 6% organic. So we have a good quarter behind us.
If we give you some highlights from the quarter, we have strong earning growth and driven by region West and Central.
As you have seen, we have some tough comparables in the north. That's why you see some negative numbers there. We'll come back to that later, but no big worries about that.
The EBITA increased with 25% to SEK383 million, out of which 6% was organic. The sales went up with 15% to about SEK4 billion this quarter, also with a good 5% organic growth.
Our EBITA margin that we have promised to get to 10% within the midterm future is also going up to 9.3% for the last 12 months.
And we have operationally in Western Central seeing some really good operational performance and some see this effects, some positive operational effects that gives us really good growth numbers
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
